ACTIVE_NOT_RECRUITING

Kebele Elimination of Trachoma for Ocular Health

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.

Official Title

Kebele Elimination of Trachoma for Ocular Health

Quick Facts

Study Start:2022-02-07
Study Completion:2028-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT03335072

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All individuals in all communities will be eligible for annual mass azithromycin distribution per WHO guidelines.
  1. * Those who do not consent.

Contacts and Locations

Principal Investigator

Tom M Lietman, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Hadley Burroughs, MSPH
STUDY_DIRECTOR
University of California, San Francisco

Study Locations (Sites)

UCSF Proctor Foundation
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Tom M Lietman, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco
  • Hadley Burroughs, MSPH, STUDY_DIRECTOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-02-07
Study Completion Date2028-03-01

Study Record Updates

Study Start Date2022-02-07
Study Completion Date2028-03-01

Terms related to this study

Keywords Provided by Researchers

  • Azithromycin
  • Mass Drug Administration
  • Antibiotic Resistance

Additional Relevant MeSH Terms

  • Trachoma